Christopher Brown

2.2k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

Christopher Brown is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Christopher Brown has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Immunology. Recurrent topics in Christopher Brown's work include CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (3 papers) and Virus-based gene therapy research (2 papers). Christopher Brown is often cited by papers focused on CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (3 papers) and Virus-based gene therapy research (2 papers). Christopher Brown collaborates with scholars based in United States, United Kingdom and Switzerland. Christopher Brown's co-authors include Julie R. Park, Michael C. Jensen, Stephanie Mgebroff, Olivia Finney, Colleen Annesley, Corinne Summers, Catherine Lindgren, Rebecca Gardner, Assaf P. Oron and Marie Bleakley and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Christopher Brown

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

2017 787 citations Rebecca Gardner, Olivia Finney et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Brown United States	12	1000	319	287	248	197	20	1.1k
Colleen Callahan United States	16	948 0.9×	299 0.9×	218 0.8×	212 0.9×	227 1.2×	33	1.1k
Hannah Brakke United States	5	1.3k 1.3×	393 1.2×	387 1.3×	343 1.4×	226 1.1×	5	1.4k
Corinne Summers United States	15	1.3k 1.3×	411 1.3×	343 1.2×	319 1.3×	253 1.3×	42	1.5k
Haneen Shalabi United States	15	777 0.8×	222 0.7×	184 0.6×	172 0.7×	124 0.6×	47	866
Reona Sakemura United States	13	717 0.7×	227 0.7×	261 0.9×	249 1.0×	261 1.3×	54	879
Anthony F. Daniyan United States	12	784 0.8×	237 0.7×	241 0.8×	326 1.3×	363 1.8×	24	1.0k
Sandhya Sharma United States	10	641 0.6×	261 0.8×	118 0.4×	251 1.0×	242 1.2×	21	735
Colette Chaney United States	13	1.3k 1.3×	432 1.4×	293 1.0×	380 1.5×	733 3.7×	19	1.7k
Maria‐Luisa Schubert Germany	20	1.0k 1.0×	339 1.1×	291 1.0×	397 1.6×	335 1.7×	40	1.2k
Kitsada Wudhikarn Thailand	14	541 0.5×	125 0.4×	68 0.2×	125 0.5×	144 0.7×	55	742

Countries citing papers authored by Christopher Brown

Since Specialization

Citations

This map shows the geographic impact of Christopher Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Brown more than expected).

Fields of papers citing papers by Christopher Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Brown. The network helps show where Christopher Brown may publish in the future.

Co-authorship network of co-authors of Christopher Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Brown. A scholar is included among the top collaborators of Christopher Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Brown. Christopher Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinto, Navin, Catherine M. Albert, Mallory Taylor, et al.. (2024). STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors. Journal of Clinical Oncology. 42(35). 4163–4172. 14 indexed citations

Ceppi, Francesco, Ashley Wilson, Colleen Annesley, et al.. (2022). Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects. Cancer Immunology Research. 10(7). 856–870. 14 indexed citations

Brown, Christopher, Alan B. Marr, Lance Stuke, et al.. (2020). Predictors of Inappropriate Helicopter Transport. The American Surgeon. 87(2). 248–252. 3 indexed citations

Gardner, Rebecca, Colleen Annesley, Ashley Wilson, et al.. (2020). Efficacy of SCRI-CAR19x22 T cell product in B-ALL and persistence of anti-CD22 activity.. Journal of Clinical Oncology. 38(15_suppl). 3035–3035. 10 indexed citations

Audino, Anthony, Leena Nahata, Daniel DaJusta, et al.. (2019). Two Successful Sperm Aspirations in High-Risk Adolescent and Young Adult Lymphoma Patients Before Initiation of Emergent Therapy. Journal of Adolescent and Young Adult Oncology. 9(2). 295–298. 1 indexed citations

Annesley, Colleen, Corinne Summers, Michael A. Pulsipher, et al.. (2019). Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses. Blood. 134(Supplement_1). 3869–3869. 11 indexed citations

Annesley, Colleen, Rebecca Gardner, Ashley Wilson, et al.. (2019). Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In Vivo. Blood. 134(Supplement_1). 223–223. 16 indexed citations

Brown, Christopher, et al.. (2019). A Comparative Case Series of Haitian and non-Haitian Stroke Patients at a Single Center in Miami, Florida. Journal of Health Care for the Poor and Underserved. 30(4). 1560–1568.

Trinconi, Cristiana T., Danilo C. Miguel, Ariel Mariano Silber, et al.. (2018). Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania. International Journal for Parasitology Drugs and Drug Resistance. 8(3). 475–487. 13 indexed citations

10.

Künkele, Annette, Christopher Brown, Stephanie Mgebroff, et al.. (2018). Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion. Biology of Blood and Marrow Transplantation. 25(2). 223–232. 23 indexed citations

11.

Annesley, Colleen, Rebecca Gardner, Olivia Finney, et al.. (2018). Novel CD19t T-Antigen Presenting Cells Designed to Re-Activate and Expand CD19 CAR T Cells In Vivo: Early Demonstration of Feasibility and Safety. Blood. 132(Supplement 1). 4021–4021. 1 indexed citations

12.

Gardner, Rebecca, Colleen Annesley, Olivia Finney, et al.. (2018). Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia. Blood. 132(Supplement 1). 278–278. 50 indexed citations

13.

Gardner, Rebecca, Olivia Finney, Colleen Annesley, et al.. (2017). Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. Blood. 129(25). 3322–3331. 787 indexed citations breakdown →

14.

Künkele, Annette, Agne Taraseviciute, Laura S. Finn, et al.. (2016). Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility. Clinical Cancer Research. 23(2). 466–477. 75 indexed citations

15.

Gardner, Rebecca, Olivia Finney, Hannah Smithers, et al.. (2016). CD19CAR T Cell Products of Defined CD4:CD8 Composition and Transgene Expression Show Prolonged Persistence and Durable MRD-Negative Remission in Pediatric and Young Adult B-Cell ALL. Blood. 128(22). 219–219. 31 indexed citations

16.

Gardner, Rebecca, Olivia Finney, Hannah Smithers, et al.. (2016). Prolonged functional persistence of CD19CAR t cell products of defined CD4:CD8 composition and transgene expression determines durability of MRD-negative ALL remission.. Journal of Clinical Oncology. 34(15_suppl). 3048–3048. 13 indexed citations

17.

Gardner, Rebecca, Julie R. Park, Karen S. Kelly‐Spratt, et al.. (2014). T Cell Products of Defined CD4:CD8 Composition and Prescribed Levels of CD19CAR/Egfrt Transgene Expression Mediate Regression of Acute Lymphoblastic Leukemia in the Setting of Post-Allohsct Relapse. Blood. 124(21). 3711–3711. 7 indexed citations

18.

Youl, Philippa, Claire Jackson, Brian Oldenburg, et al.. (2006). Attitudes, knowledge and practice of CRC screening among GPs in Queensland.. PubMed. 35(7). 547–50. 6 indexed citations

19.

Kayembé, Patrick, et al.. (1992). Neurological complications of HIV-1-seropositive internal medicine inpatients in Kinshasa, Zaire.. PubMed. 5(4). 333–40. 34 indexed citations

20.

Cundy, Tim, et al.. (1979). Concentrations of amoxycillin in serum and dialysate of uraemic patients undergoing peritoneal dialysis. Journal of Infection. 1(3). 235–242. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact